Asia Pacific Drug Delivery System Market

The Asia Pacific drug delivery systems market is expected to reach US$ 441,337.0 Mn in 2027 from US$ 212,012.7 in 2018. The market is estimated to grow with a CAGR of 8.6% from 2019-2027.

In Asia Pacific, various routes of administration are being studied in order to treat these chronic diseases. According to the estimates by The Asia Pacific Burden of Disease, the death rate of CVD is approximately 272 per 100,000 people in India, which is comparatively higher than the Asia Pacific average (i.e., 235 per 100 000 population). Similar trends for the increased prevalence of diabetes is witnessed among Asian countries such as Australia, China, South Korea, and Australia. For instance, as per IDF Diabetes Atlas published by the International Diabetes Federation in 2017, South-East Asia consists of almost one-fifth (19%) of the Asia Pacific diabetes population. As per the data published by the World Health Organization (WHO), in 2014, around 230 million people in China had CVD. Also, by 2030, the number is predicted to increase by 50% considering the aging Chinese population and growth. Additionally, by 2030, cardiovascular disease will cost $ 1,044 billion to the Chinese government. Rising geriatric population and related chronic diseases are expected to drive the sales of medical devices, hence leading to the growth of the market in the Asia Pacific over the forecast years. The problem of growing prevalence of cancer is increasing in APAC.  The region reports Japan, Taiwan, Singapore, South Korea, Malaysia, Thailand, China, Philippines, Sri Lanka, Vietnam, Indonesia, Mongolia, India, Laos, and Cambodia as the top 15 countries with cancer prevalence. Owing to Increasing Chronic Diseases Cases, the drug delivery systems market is likely to propel the growth in the forecast period.

China is anticipated to lead the adoptions of drug delivery systems across the Asia Pacific region through the forecast period. Growing research activities in drug delivery technology, increasing significant prevalence of disease and rising number of collaborations and partnerships in advance science and innovation. China is also expected to provide lucrative opportunities to local as well as international players to manufacture and market drug delivery devices in the country over the forecast years.

China Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)

Asia Pacific Drug Delivery System Strategic Insights

Strategic insights for the Asia Pacific Drug Delivery System provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Drug Delivery System Report Scope

Asia Pacific Drug Delivery System Regional Insights

The geographic scope of the Asia Pacific Drug Delivery System refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Asia Pacific Drug Delivery Systems Market Segmentation

By

Route of Administration

• Oral
  • Solid Oral Drugs
  • Liquid Oral Drugs
  • Semi-solid Oral Drugs
• Transmucosal
  • Pulmonary Drug Delivery
    • In-metered Dose Inhalers
    • Dry Powder Inhalers
    • Nebulizers
  • Nasal Drug Delivery
    • Nasal Sprays
    • Nasal Drops
    • Nasal Gels
  • Buccal Drug Delivery
  • Sublingual Drug Delivery
  • Rectal Transmucosal Drug delivery
  • Vaginal Transmucosal Drug Delivery
• Injectable
  • Conventional Injection Devices
  • Self-Injection Devices
    • Needle Free Injectors
    • Pen Injectors
    • Wearable Injectors
• Topical
  • Semi-solid Topical Drug Delivery Formulations
  • Liquid Topical Drug Delivery Formulations
  • Solid Topical Drug Delivery Formulations
  • Transdermal Patches
  • Transdermal Gels
  • Others
• Implantable
  • Active Implantable
  • Passive Implantable
• Ocular
  • Eye Drops & Sprays
  • Gels & Ointments
  • Ocular Inserts
  • Drug Coated Contact Lenses

• Hospital & Clinics
• Home Care Settings
• Others

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

• Asia Pacific

  • China
  • Japan
  • India

Companies Mentioned

• 3M
• MYLAN N.V.
• ABBOTT
• F. HOFFMANN-LA ROCHE AG
• JOHNSON & JOHNSON
• NOVARTIS
• ANTARES PHARMA
• BAXTER
• MERCK & CO., INC.
• BECTON, DICKINSON AND COMPANY